機械学習から因果的洞察へ:全身性炎症反応症候群とセプシスリスクを区別するための堅固な12遺伝子シグネチャー
Bing E1, Liaoyue Chen2, Shaoting Luo3
1Department of Pediatric Orthopedics, Shenzhen Children's Hospital, No. 7019 Yitian Road, Futian District, Shenzhen, 518000, Guangdong, PR China.
European journal of medical research
|February 21, 2026
まとめ
この研究では,全身性炎症 (SIRS) とセプシスを正確に区別するための12遺伝子シグネチャーが特定されました. このセプシスのバイオマーカーの発見は,早期診断と改善された患者のアウトカムの可能性を提供します.
科学分野:
- バイオマーカーの発見
- ゲノミクスゲノミクスとは
- 計算生物学とは,計算生物学である.
背景:
- セプシスは,複雑な宿主反応のために診断上の課題を提示します.
- 非感染性全身性炎症反応症候群 (SIRS) とセプシスを区別することは,適切な介入に不可欠です.
研究 の 目的:
- SIRSとセプシスを区別するための強力な遺伝子発現バイオマーカーを特定する.
- セプシス診断のための予測シグネチャーを開発する.
主な方法:
- 公的な遺伝子発現オムニバス (GEO) データセットの分析.
- 微分発現分析,加重遺伝子共発現ネットワーク分析 (WGCNA),および113の機械学習モデルの応用.
- 免疫浸透,単細胞RNAシーケンシング (scRNA-seq),メンデルのランダム化 (MR) を用いたハブ遺伝子の調査,インビトロおよびインビボの検証.
主要な成果:
- 12遺伝子シグネチャーは,強力な外部検証で,SIRSとセプシスを区別する際に高い精度 (AUC 0.998) を達成しました.
- メンデルのランダム化により,EIF4G3発現の増加と敗血症のリスクとの間の因果関係が示唆されました.
- scRNA-seqは,DNAJC5.5を含むハブ遺伝子発現の主要な部位として,ミエロイド細胞を特定しました.
結論:
- 検証された12遺伝子シグネチャーは,セプシスとSIRSを効果的に区別する.
- EIF4G3とDNAJC5は,早期のセプシス診断のための潜在的なバイオマーカーとして有望を示しています.
- このサインは,迅速な治療介入のために,高リスクの患者を特定するのに役立ちます.
関連する概念動画
The Ratio of X Chromosome to Autosomes
In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Sex Linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...

